Cinqair is a prescription medicine used to treat the symptoms of Asthma. Cinqair may be used alone or with other medications.

Cinqair belongs to a class of drugs called Interleukin Inhibitors; Monoclonal Antibodies, Anti-asthmatics.

CINQAIR (reslizumab) is a humanized interleukin-5 antagonist monoclonal antibody (IgG4κ). Reslizumab is produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells. Reslizumab has a molecular weight of approximately 147 kDa.

Cinqair Info

CINQAIR is for intravenous infusion only. Do not administer as an intravenous push or bolus.

The recommended dosage regimen is 3 mg/kg once every 4 weeks administered by intravenous infusion over 20-50minutes.

Cinqair Side Effects

The most common side effects include: 

  • sore throat, and
  • muscle pain


Patient Assistance Programs

There are several programs patients can sign up for that will assist in treatment costs:


To learn more about this treatment, browse the resources below.

Order Form

To download the order form for this treatment, click below.

Ready to get started?

Contact us to chat with one of our helpful scheduling specialists!